XENE
Xenon Pharmaceuticals Inc.
+0.49 (+0.86%)57.25USD413K成交股數5.5B市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-02下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 0.00 | 0.00-100% | 0.00 | 0.00 | 0.00 | 7.5M | 0.00 | 0.00 | 0.00 | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 99.2M | 88.5M | 87.7M | 77.1M | 75.0M | 61.2M | 57.0M | 49.7M | 44.3M | 41.1M | 42.9M | 44.0M |
| 銷售管理費用 | 23.9M | 23.8M | 22.1M | 19.3M | 19.2M | 19.0M | 16.7M | 19.4M | 14.8M | 12.6M | 12.8M | 11.6M |
| 營業利益 | −123M+31% | −112M+54% | −110M+49% | −96.3M+39% | −94.2M+60% | −72.7M+35% | −73.7M+32% | −69.1M+24% | −59.0M | −53.7M | −55.7M | −55.6M |
| 營業利益率 | – | – | – | – | – | -969.8% | – | – | – | – | – | – |
| 稅後淨利 | −111M+31% | −102M+57% | −105M+68% | −90.9M+57% | −84.7M+77% | −65.0M+45% | −62.8M+30% | −57.9M+22% | −47.9M | −44.7M | −48.5M | −47.5M |
| 淨利率 | – | – | – | – | – | -867.3% | – | – | – | – | – | – |
| 稀釋 EPS | -1.11+4% | -1.17+41% | -1.31+62% | -1.15+53% | -1.07+73% | -0.83+28% | -0.81+11% | -0.75+4% | -0.62 | -0.65 | -0.73 | -0.72 |
| 稀釋股數 | 99.6M | 87.3M | 79.3M | 79.2M | 79.0M | 78.7M | 77.9M | 77.7M | 77.6M | 66.9M | 66.0M | 65.9M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 120M | 546M | 199M | 105M | 135M | 117M | 87.6M | 137M | 58.9M | 149M | 99.6M | 64.6M |
| 應收帳款 | – | – | – | – | – | – | 938K | 853K | 833K | 874K | 805K | 2.1M |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 1.3B | 1.4B | 633M | 608M | 674M | 743M | 836M | 884M | 919M | 965M | 671M | 685M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 53.4M | 49.0M | 51.4M | 48.3M | 40.3M | 39.3M | 38.1M | 40.0M | 31.3M | 36.9M | 34.5M | 38.4M |
| 股東權益 | 1.2B | 1.3B | 582M | 560M | 634M | 704M | 798M | 844M | 888M | 928M | 637M | 646M |
| 負債比 | 4.1% | 3.5% | 8.1% | 8.0% | 6.0% | 5.3% | 4.6% | 4.5% | 3.4% | 3.8% | 5.1% | 5.6% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −88.9M+44% | – | – | – | −61.7M | – | – | −46.2M | – | – | – |
| 資本支出 | – | 133K | – | – | – | 43K | – | – | 188K | – | – | – |
| 自由現金流 | – | −89.0M+44% | – | – | – | −61.7M | – | – | −46.4M | – | – | – |
| 折舊攤銷 | – | 587K | – | – | – | 659K | – | – | 586K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | -822.6% | – | – | – | – | – | – |
營收拆解 2024 年度 10-K 的分部揭露 · 年增對前一年度
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 7.5M | – | −346M | -4,612.1% | -4.36 | −280M |
| FY2024 | 0.00 | – | −234M | –% | -3.01 | −184M |
| FY2023 | 0.00 | -100.0% | −182M | –% | -2.73 | −157M |
| FY2022 | 9.4M | -48.8% | −125M | -1,328.9% | -2.06 | −104M |
| FY2021 | 18.4M | -42.7% | −78.9M | -427.8% | -1.77 | −71.6M |
| FY2020 | 32.2M | +371.0% | −28.8M | -89.7% | -0.81 | −50.8M |
| FY2019 | 6.8M | – | −41.6M | -609.1% | -1.54 | −6.0M |
| FY2018 | – | – | −34.5M | –% | -1.63 | −35.2M |